Latiglutenase
Search documents
First Wave BioPharma(FWBI) - Prospectus(update)
2025-09-10 21:19
As filed with the Securities and Exchange Commission on September 10, 2025 Registration Statement No. 333-289864 UNITED STATES SECURITIES AND EXCHANGE COMMISSION (State or other jurisdiction of incorporation or organization) Delaware 2834 46-4993860 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) Washington, D.C. 20549 777 Yamato Road, Suite 502 Boca Raton, Florida 33431 (561) 589-7020 (Address, including zip code, and telephone number, including area code, o ...
Entero Therapeutics, Inc.(ENTO) - Prospectus(update)
2025-09-10 21:19
As filed with the Securities and Exchange Commission on September 10, 2025 Registration Statement No. 333-289864 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A (Amendment No. 1) REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ENTERO THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 2834 46-4993860 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer ...
First Wave BioPharma(FWBI) - Prospectus
2025-08-26 20:28
As filed with the Securities and Exchange Commission on August 26, 2025 Registration Statement No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ENTERO THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) Delaware 2834 46-4993860 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 777 Y ...